CpK R&D Invents Anti-Viral Plastics to Eliminate COVID-19
Mario CywinskiHealth & Safety Industry Manufacturing Operations Manufacturing canada coronavirus covid-19 covid19 editor pick fca manufacturing operations Plant production
CpK Interior Products Inc. has developed a line of patent pending anti-viral plastics, which can eliminate COVID-19 on material surfaces in under an hour.
“This was no simple task, but our team had experience inventing novel materials in the past,” said Farrar “Not only did CpK have to discover which materials could actively attack the DNA of coronavirus, we also had to navigate the stringent and timely quality and testing requirements for new automotive interior materials.”
CpK was able to invent, test, and apply for a patent within 90 days of the project kickoff. Led by Dr. Gregory Farrar, Head of R&D, CpK, the team was tasked to create material for car interiors that showed anti-viral activity. CpK invented cast skin materials for Dodge Challenger and Dodge Charger.
“A single test such as UV resistance and heat aging can typically take up to 21 days to complete, but we were able to have prototype parts sent to FCA within a month of kicking off the project,” said Farrar.
Anti-viral testing was another challenge, but CpK was able to contract the ImPaKT facility at Western University’s Schulich School of Medicine & Dentistry, to collaborate and perform testing.
“Because the entire supply chain from raw material to finished product is all under the same CpK umbrella, we are able to invent, test, and prototype new material with speed and agility,” said Ted Castle, Managing Director. “This ability played a key role in the success of the anti-viral project.”